Adverse events236

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 236

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Cardiomyopathy	Cardiac disorders	Biologic Disease Modifying Anti-Rheumatic Drugs (BDMARD) Naive	1	221
other	Cardiomyopathy	Cardiac disorders	Participants Who Switched From Remicade to CT-P13	0	107
other	Uveitis	Eye disorders	Biologic Disease Modifying Anti-Rheumatic Drugs (BDMARD) Naive	2	221
other	Uveitis	Eye disorders	Participants Who Switched From Remicade to CT-P13	0	107
other	Abdominal distension	Gastrointestinal disorders	Biologic Disease Modifying Anti-Rheumatic Drugs (BDMARD) Naive	1	221
other	Abdominal distension	Gastrointestinal disorders	Participants Who Switched From Remicade to CT-P13	0	107
other	Abdominal pain	Gastrointestinal disorders	Biologic Disease Modifying Anti-Rheumatic Drugs (BDMARD) Naive	3	221
other	Abdominal pain	Gastrointestinal disorders	Participants Who Switched From Remicade to CT-P13	0	107
other	Aphthous ulcer	Gastrointestinal disorders	Biologic Disease Modifying Anti-Rheumatic Drugs (BDMARD) Naive	1	221
other	Aphthous ulcer	Gastrointestinal disorders	Participants Who Switched From Remicade to CT-P13	0	107
other	Dyspepsia	Gastrointestinal disorders	Biologic Disease Modifying Anti-Rheumatic Drugs (BDMARD) Naive	1	221
other	Dyspepsia	Gastrointestinal disorders	Participants Who Switched From Remicade to CT-P13	0	107
other	Asthenia	General disorders	Biologic Disease Modifying Anti-Rheumatic Drugs (BDMARD) Naive	1	221
other	Asthenia	General disorders	Participants Who Switched From Remicade to CT-P13	0	107
other	Cyst	General disorders	Biologic Disease Modifying Anti-Rheumatic Drugs (BDMARD) Naive	0	221
other	Cyst	General disorders	Participants Who Switched From Remicade to CT-P13	1	107
other	Drug ineffective	General disorders	Biologic Disease Modifying Anti-Rheumatic Drugs (BDMARD) Naive	25	221
other	Drug ineffective	General disorders	Participants Who Switched From Remicade to CT-P13	6	107
other	Impaired healing	General disorders	Biologic Disease Modifying Anti-Rheumatic Drugs (BDMARD) Naive	0	221
other	Impaired healing	General disorders	Participants Who Switched From Remicade to CT-P13	1	107

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02605642/events

API reference For AI assistants

Adverse events236

Sources 3

Read this list from software.